T1	Participants 145 179	patients with chronic hepatitis B.
T2	Participants 320 338	Caucasian patients
T3	Participants 344 377	chronic active hepatitis B (CAHB)
T4	Participants 382 396	Asian patients
T5	Participants 623 713	10 Chinese patients with histologically proven CAHB and seven healthy Chinese individuals.
T6	Participants 2174 2195	Chinese CAHB patients
T7	Participants 2224 2252	Caucasian patients with CAHB
